Exact Sciences Cor (EXAS)
$66.37 3.77 (6.02%)
19:25 EDT EXAS Stock Quote Delayed 20 Minutes
Previous Close $66.37
Market Cap 8.09B
PE Ratio -66.37
Volume (Avg. Vol.) 1.96M
Day's Range 61.60 - 66.55
52-Week Range 35.25 - 123.99
Dividend & Yield N/A (N/A)
EXAS Stock Predictions, Articles, and Exact Sciences Cor News
- From InvestorPlace
- From the Web
The future of healthcare will really start to take shape this year, and the next decade will bring advancements that we can only imagine in our wildest dreams.
These ten growth stocks saw the highest percentage growth over the last decade, and some remain unknown to investors despite huge increases.
The 13-F filing for Warren Buffett's Berkshire Hathaway is out. Here's what happened in the stock market today.
These drug stocks are among the best to buy now because each is making progress in the fight against cancer. Here's what you should know about each.
Which top stocks are Wall Street analysts the most bullish on? These strong buy stocks deserve a spot on your watch list.
InVitae, Crispr and Myriad are just some of the genomic testing stocks worth a look as DNA becomes a more important part of healthcare.
We explain the surge of MBOT stock and describe the products that could lead to much higher prices for Microbot stock in the future.
These biotech stocks are set for a strong comeback as investors start to walk away from large-cap tech companies. Here's what investors need to know about each company.
Exact Sciences is a rapidly growing biotech firm whose decline looks overdone. Seasonal strength in the second quarter could renew bullish sentiment in EXAS stock.
Exact Sciences (EXAS) drops to a Buy this week based on the latest news, and comparative pricing of its shares.
3 Stocks to Watch on Friday: Advanced Micro Devices, Inc. (AMD), EXACT Sciences Corporation (EXAS) and International Business Machines Corp. (IBM)
Advanced Micro Devices (AMD) said chips have vulnerability, EXACT Sciences (EXAS) launches $500M offering and IBM (IBM) to cut 10,000 jobs.
Profitability analysis is used to measure the company’s ability to manage its revenues effectively and provide stunning returns to its investors.
Biotechs have stabilized and offer the potential to deliver substantial returns. Here are 5 biotech stocks that fit our investment criteria
From Market News Video
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader